WithParkinson’s disease, facial masking is typically brought on by a progressive loss of motor control.
The inability to recognize sadness, fear, and other emotions creates a barrier in relationships.
Treatment
Facial expression matters.
supersizer / Getty Images
They include levodopa (L-dopa), a drug often used to replace dopamine.
Researchers have demonstrated a link between facial masking symptoms and low dopamine responses.
Summary
Facial masking is a common symptom of Parkinson’s disease.
The inability to move the face, also called hypomimia, limits expression and connection with others.
Your healthcare provider can assess facial masking symptoms using standard tools and examinations.
Therapy and medications can help people to manage their symptoms and improve their quality of life.
2020 Dec;27(12):2422-2429. doi:10.1111/ene.14452.
2024 Jan 22;14(1):109. doi:10.3390/brainsci14010109
Parkinson’s Foundation.Facial masking.
University of Florida Health.Unified Parkinsons Disease Rating Scale.
2018 Apr;33(4):554-567. doi:10.1002/mds.27305
Parkinson’s Foundation.Levodopa.
American Parkinson’s Disease Association.Medications used to treat the motor symptoms of Parkinsons disease as of November 2024.
American Parkinson’s Disease Association.Limited Expressions: Facial Masking and Parkinsons Disease.
